Package 61703-305-38

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 61703-305-38
Digits Only 6170330538
Product NDC 61703-305
Product ID 61703-305_d8c6ffbd-a0d9-4094-a6ea-d94cb93c5c2d
Description

5 VIAL, SINGLE-DOSE in 1 CARTON (61703-305-38) / 5 mL in 1 VIAL, SINGLE-DOSE (61703-305-58)

Marketing

Marketing Status
Marketed Since 1990-06-04
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

Cytarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "d8c6ffbd-a0d9-4094-a6ea-d94cb93c5c2d", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["1731355"], "spl_set_id": ["bc2fa221-ea56-48b8-8304-42cd81b8463b"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (61703-305-38)  / 5 mL in 1 VIAL, SINGLE-DOSE (61703-305-58)", "package_ndc": "61703-305-38", "marketing_start_date": "19900604"}], "brand_name": "Cytarabine", "product_id": "61703-305_d8c6ffbd-a0d9-4094-a6ea-d94cb93c5c2d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "61703-305", "generic_name": "CYTARABINE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "20 mg/mL"}], "application_number": "ANDA071868", "marketing_category": "ANDA", "marketing_start_date": "19900604", "listing_expiration_date": "20261231"}